Trial Profile
A study investigating the effect of adalimumab and relation between joint involvement and severity of skin disease in psoriatic arthritis patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- 12 Dec 2015 New trial record